As of 2025-09-18, the EV/EBITDA ratio of AnaptysBio Inc (ANAB) is -3.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AnaptysBio's latest enterprise value is 510.38 mil USD. AnaptysBio's TTM EBITDA according to its financial statements is -150.59 mil USD. Dividing these 2 quantities gives us the above AnaptysBio EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 12.6x | 8.4x |
| Forward P/E multiples | 13.3x - 18.8x | 17.4x |
| Fair Price | (70.06) - (65.97) | (67.80) |
| Upside | -453.6% - -433.0% | -442.2% |
| Date | EV/EBITDA |
| 2025-09-12 | -4.06 |
| 2025-09-11 | -4.02 |
| 2025-09-10 | -3.94 |
| 2025-09-09 | -3.82 |
| 2025-09-08 | -3.83 |
| 2025-09-05 | -3.78 |
| 2025-09-04 | -3.63 |
| 2025-09-03 | -3.89 |
| 2025-09-02 | -3.54 |
| 2025-08-29 | -3.49 |
| 2025-08-28 | -3.45 |
| 2025-08-27 | -3.50 |
| 2025-08-26 | -3.42 |
| 2025-08-25 | -3.44 |
| 2025-08-22 | -3.47 |
| 2025-08-21 | -3.49 |
| 2025-08-20 | -3.45 |
| 2025-08-19 | -3.39 |
| 2025-08-18 | -3.43 |
| 2025-08-15 | -3.45 |
| 2025-08-14 | -3.42 |
| 2025-08-13 | -3.56 |
| 2025-08-12 | -3.44 |
| 2025-08-11 | -3.42 |
| 2025-08-08 | -3.62 |
| 2025-08-07 | -3.49 |
| 2025-08-06 | -3.90 |
| 2025-08-05 | -4.11 |
| 2025-08-04 | -4.21 |
| 2025-08-01 | -4.30 |
| 2025-07-31 | -4.27 |
| 2025-07-30 | -4.35 |
| 2025-07-29 | -4.58 |
| 2025-07-28 | -4.65 |
| 2025-07-25 | -4.71 |
| 2025-07-24 | -4.72 |
| 2025-07-23 | -4.73 |
| 2025-07-22 | -4.58 |
| 2025-07-21 | -4.57 |
| 2025-07-18 | -4.53 |
| 2025-07-17 | -4.67 |
| 2025-07-16 | -4.70 |
| 2025-07-15 | -4.66 |
| 2025-07-14 | -4.72 |
| 2025-07-11 | -4.58 |
| 2025-07-10 | -4.56 |
| 2025-07-09 | -4.49 |
| 2025-07-08 | -4.21 |
| 2025-07-07 | -4.07 |
| 2025-07-03 | -4.12 |